We are pleased to share that Dr. Nelli Ghicavii, Aurelia Siranu, and Megan Morris will represent ARENSIA at the American College of Cardiology Annual ...
READ MOREWe’ve expanded into one of Latin America’s most dynamic clinical research hubs, bringing faster access to innovative therapies where it ma...
READ MOREDr. Ileana Stoicescu, Head of ARENSIA’s Oncology Unit in Bucharest, was part of the conference “Challenges and Perspectives in Onco-Hemato...
READ MOREPsoriasis is a chronic autoimmune disease affecting more than 60 million people worldwide. Beyond skin manifestations, it is a systemic inflammatory c...
READ MOREARENSIA continues to strengthen its expertise in advanced cell therapies. We are currently conducting CAR-T clinical trials in immunology and exp...
READ MOREWe are thrilled to announce that ARENSIA’s Phase I research clinic in Cluj-Napoca, Romania, has formed a strategic partnership with the Universi...
READ MOREDriving progress in relapsed or refractory acute myeloid leukemia, at ARENSIA's newest clinic in Ukraine! We were pleased to welcome the Molecu...
READ MOREWe are excited to announce the launch of ARENSIA’s Phase 1 patient clinic in Buenos Aires, Argentina! Our year-long diligence and selection p...
READ MORETwelve years after launching its Phase 1 oncology clinic in Chișinău, Moldova, ARENSIA is proud to expand its footprint with a new 1,000 sqm (11,000...
READ MOREARENSIA DOSES FIRST PATIENT IN GROUNDBREAKING HEPATITIS B GENE EDITING TRIAL ARENSIA Research Clinic is proud to announce that we have dosed the wo...
READ MOREReflecting on 2024, we are deeply grateful for your research endeavors and trust. Your innovation and support have driven our growth and inspired us t...
READ MOREWe are thrilled to announce that ARENSIA’s clinic in Ukraine has successfully dosed the very first patient in an advanced Phase 1 study for Non-...
READ MORE